US2013252347A1PendingUtilityA1
Diagnostic method
Est. expiryJun 12, 2027(~0.9 yrs left)· nominal 20-yr term from priority
G01N 33/6893G01N 2800/26G01N 33/569A61P 31/04A61B 5/00A61K 39/00G01N 33/575
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
It has been demonstrated that the level of HBP increases in individuals that subsequently develop severe sepsis. Accordingly, the level of HBP, HBP/WBC ratio or HBP/NC ratio in an individual can be used to determine whether or not an individual is at risk of developing severe sepsis.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . An agent for the detection of HBP for use in determining whether or not an individual is at risk of developing severe sepsis.
17 . An agent according to claim 16 wherein the agent comprises an HBP-specific antibody.
18 - 21 . (canceled)
22 . A test kit for use in a method for determining whether or not an individual is at risk of developing severe sepsis, which test kit comprises an agent for the detection of HBP in an individual.
23 . The kit of claim 21 additionally comprising means for the measurement of the WBC in an individual.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.